An interventional study of Incentives to be vaccinated and Mask in Vaccination Refusal, sponsored by Yale University. Completed at 1 site in India. Open to participants aged 15 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-22.
Sponsored by Yale University · Not applicable, Interventional, and Prevention
Working with governments in Bihar, India, we will evaluate a number of mechanisms to increase vaccine uptake. These include household vaccination visits instead of community vaccination clinic.monetary and non-monetary incentives, and concurrent mask promotion. This ClinicalTrials entry contains results only for the study in Bihar.
The goal of the study is to identify strategies that best promote and support COVID vaccine uptake in developing countries, we propose to test a range of scalable social and behavioural interventions. This could help policy makers design and employ interventions that are effective. This is especially valuable in resource constrained contexts where funds and institutional resources can be diverted towards interventions that have proven to work.
In Bihar the intervention will be village-level social mobilization involving community promotion, including in-person vaccine reinforcement, and household-level social mobilization. Some treatment villages will receive household- level interventions with varying intensity (different proportion of households will be visited). There will also an accompanying mask distribution campaign during household visits where the importance of mask-wearing as a complement to vaccine use will be explained.
This ClinicalTrials entry contains results only for the study in Bihar.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 114,512 is above the median of 100 across 4,099 interventional studies indexed under COVID-19.
Browse COVID-19 studies →Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.
Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
No vaccine or mask promotion, but access to vaccines increased to match access in intervention villages
Village-level vaccine clinics with monetary, non-monetary, or no incentive. Villages are cross-randomized to grocery coupon, food ration, no incentive, or grocery coupon to both community member and community health worker after the community member has received a vaccination.
Behavioral: Incentives to be vaccinated · Behavioral: Vaccination made more convenient · Behavioral: Social mobilization campaign to be vaccinated
Household-level vaccination with monetary incentive or no incentive. Villages are cross-randomized to grocery coupon or no incentive upon receiving vaccination
Behavioral: Incentives to be vaccinated · Behavioral: Vaccination made more convenient · Behavioral: Social mobilization campaign to be vaccinated
Individuals are encourage to attend village-level vaccine clinics but not given any incentive. Mask distribution and reinforcement activities are conducted in villages at a similar time as vaccine promotion.
Device: Mask · Behavioral: Encouragement to wear a mask · Behavioral: Vaccination made more convenient · Behavioral: Social mobilization campaign to be vaccinated
Individuals are encourage to attend village-level vaccine clinics but not given any incentive.
Behavioral: Vaccination made more convenient · Behavioral: Social mobilization campaign to be vaccinated
Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated
Individuals are given cloth masks
Individuals who are not wearing masks over their mouth and nose are stopped in public places and encouraged to wear a mask
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
Percent of individuals who receive the first, second, or third dose of covid vaccine
Prevalence of vaccination with difference doses
Time frame: up to 4 weeks (endline may vary depending on estimated uptake rates)
This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yale University